Streptomyces phytophilus sp. nov., an endophytic actinobacterium with biosynthesis potential as an antibiotic producer
International Journal of Systematic and Evolutionary Microbiology · 2023
DOI: 10.1099/ijsem.0.005834 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Systematic and Evolutionary Microbiology, 2023. Verfasst von Onuma Kaewkla und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Mahasarakham University, Maha Sarakham Province, 44150, Thailand. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Streptomyces, Actinobacteria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Mahasarakham University.
Abstract (Originalsprache)
An endophytic actinobacterium, strain PIP175 T , was isolated from the root sample of a native apricot tree ( Pittosporum angustifolium ) growing on the Bedford Park campus of Flinders University, Adelaide, South Australia. This strain is a Gram stain-positive, aerobic actinobacterium with well-developed substrate mycelia. Aerial mycelia rarely produce spores and the spore chain is spiral. Strain PIP175 T showed the highest 16S rRNA gene sequence similarity to Streptomyces aculeolatus DSM 41644 T (99.4 %). Other closely related phylogenetic representatives include Streptomyces synnematoformans DSM 41902 T (98.3 %), Streptomyces albospinus NBRC 13846 T (97.6 %), Streptomyces cacaoi subsp. cacaoi NRRL B-1220 T (97.5 %) and Streptomyces ruber NBRC 14600 T (97.4 %). The major cellular fatty acid of this strain was iso-C 16 : 0 and the major menaquinone was MK-9(H 6 ). The whole-cell sugar contained galactose, glucose and mannose. Chemotaxonomic data confirmed that strain PIP175 T belonged to the genus Streptomyces . Digital DNA–DNA hybridization, average nucleotide identity based on blast and OrthoANIu results between strain PIP175 T and S. aculeolatus DSM 41644 T were 60.0, 94.1 and 94.9 %, respectively. Genotypic and phenotypic data and genome analysis results allowed the differentiation of strain PIP175 T from its closest species with validly published names. Strain PIP175 T showed good activity against methicillin-resistant Staphylococcus aureus 03120385. Genome mining of strain PIP175 T revealed biosynthetic genes encoding proteins relating to antibiotic production, plant growth promotion and biodegradation enzymes. The name proposed for the new species is Streptomyces phytophilus sp. nov. The type strain is PIP175 T (=DSM 103379 T =TBRC 6026 T ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Faculty of Science, Mahasarakham University, Maha Sarakham Province, 44150, Thailand.
- Department of Medical Biotechnology, College of Medicine and Public Health, Flinders University, Bedford Park, Adelaide, 5042, Australia.
- Thailand Bioresource Research Center (TBRC), National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Klong Luang, Pathumthani 12120, Thailand.
Förderung
- Mahasarakham University
Zitieren
APA
Kaewkla, O., Suriyachadkun, C., & Franco, C. M. M. (2023). Streptomyces phytophilus sp. nov., an endophytic actinobacterium with biosynthesis potential as an antibiotic producer. International Journal of Systematic and Evolutionary Microbiology. https://doi.org/10.1099/ijsem.0.005834
Vancouver
Kaewkla O, Suriyachadkun C, Franco CMM. Streptomyces phytophilus sp. nov., an endophytic actinobacterium with biosynthesis potential as an antibiotic producer. International Journal of Systematic and Evolutionary Microbiology. 2023. doi:10.1099/ijsem.0.005834
BibTeX
@article{Kaewkla2023,
author = {Kaewkla, Onuma and Suriyachadkun, Chanwit and Franco, Christopher Milton Mathew},
title = {Streptomyces phytophilus sp. nov., an endophytic actinobacterium with biosynthesis potential as an antibiotic producer},
journal = {International Journal of Systematic and Evolutionary Microbiology},
year = {2023},
doi = {10.1099/ijsem.0.005834}
}
EUVIMED